Credit Suisse Upgrades Medtronic (MDT) to Outperform
More News related to MDT
- Medtronic CEO William Hawkins to Speak at 21st Annual Piper Jaffray Healthcare Conference
- Highlights From MDT's Q3 Conference Call: U.S. Revenues up 5%, International Sales Up 13%; Guides Above for FY10
- Medtronic's (MDT) Earnings and Guidance Shows A Strong Heart Beat
- Medtronic (MDT) Tops Q3 Views; Guides FY10 EPS Above the Street
- Medtronic Second Quarter Revenue Increases 8% to $3.838 Billion; Raises EPS Guidance for Current Fiscal Year
Credit Suisse upgrades Medtronic, Inc. (NYSE: MDT) from Neutral to Outperform.
Medtronic, Inc. develops, manufactures, and sells device-based medical therapies worldwide.
Related Categories
UpgradesStocks Mentioned
-0.07Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
